Multimodality Therapy for Stage IIIA (N2) Lung Cancer

Determination of the eventual role of aggressive, multimodality therapy in the treatment of locally advanced lung cancer awaits the results of these and other trials. Ultimately, however, it is hoped that these studies will lead to improved prospects for the many patients who present with lung cancer that was previously considered inoperable.